AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03589131 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative data
Description: These include distance of the tumor from the anal verge, clinical stage, whether preoperative chemoradiation CRT, presence of residual tumor after CRT. All were analyzed and compared
Study NCT04423432 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Electrotherapy + Heating
Description: Iinterferential Current therapy (2P), in combination with heating pad for 20 minutes
Study NCT04423432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrotherapy + Heating
Description: Iinterferential Current therapy (2P), in combination with heating pad for 20 minutes
Study NCT04423432 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Joint Mobilization
Description: 1. Tibio-femoral Anterior Glide~2. Tibio-femoral Posterior Glide~3. Patellofemoral Joint Mobilization
Study NCT04423432 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Joint Mobilization
Description: 1. Tibio-femoral Anterior Glide~2. Tibio-femoral Posterior Glide~3. Patellofemoral Joint Mobilization
Study NCT04423432 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Creatine Supplementation
Description: Creatine Supplementation 20g/day for 1 week followed by 5 g/day for 3 weeks
Study NCT04423432 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Glucoseamine/ Chondritin Sulfate Supplementation
Description: Glucoseamine/ Chondritin Sulfate Supplementation (500mg+400mg/day)
Study NCT03683979 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interpretation Bias Modification
Description: A computer based interpretation bias modification program that aims to reinforce neutral interpretations of ambiguous social situations.
Study NCT03683979 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control Training Program
Description: A sham training program that is similar in design and delivery to the experimental training condition.
Study NCT03122184 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Psychology + Motivational Interviewing
Description: For the positive psychology portion of the intervention, the study trainer will (a) review the week's positive psychology exercise, (b) discuss the rationale of the next week's positive psychology exercise through a guided review of the positive psychology manual, and (c) assign the next week's positive psychology exercise. For the motivational interviewing portion, participants will (a) review their physical activity goal from the prior week, (b) discuss techniques for improving physical activity, and (c) set a physical activity goal for the next week. Study trainers will use motivational interviewing techniques to facilitate goal setting.
Study NCT03122184 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Motivational Interviewing Health Education
Description: Each week, participants will learn about a different health behavior topic related to cardiac health. They will also be introduced to motivational interviewing topics in concert with the health behavior education topics. The intervention is divided into five sections, focusing on five different important cardiac health-related topics (recovery from an acute cardiac illness, physical activity, a heart-healthy diet, medication adherence, and stress reduction).
Study NCT03589131 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Postoperative data
Description: These include pathological stage, number of harvested lymph nodes and immediate postoperative outcome within one month (days of return of bowel function, days of hospital stay, complications, if any, like anastomotic leakage, ileus,wound problems and others, rate of reoperation, rate of readmission \& 30-days mortality. All were analyzed and compared
Study NCT00690339 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Style 410 Silicone-Filled Breast Implants
Description: Breast Implant Surgery
Study NCT04266873 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AffloVest
Description: Form of High Frequency Chest Wall Oscillation mimicking manual techniques on a patients thorax to assist with secretion clearance. Delivered for 30 minutes, twice a day
Study NCT04423900 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: smart phone application
Description: Participants will be asked to provide information about their sociodemographic characteristics, chronic diseases, the history of the ankle injury, trauma, and surgery, the severity of the foot pain via using the mobile application.The app will be downloaded from the Google Play Store and available offline. Information from the patient will be stored in an SQLite database.The usability test will be carried out on the mobile application so that the latest releases contain clear, effective, loyal to the strategy, and easily understood messages by the intended audience and do not produce unwanted responses.Direct observation, individual interviews, and satisfaction surveys will be used to identify areas of improvement in a cross-sectional manner.Investigation of pes cavus, pes planus and ankle range of motion will be determined by image processing.All data can be analyzed and stored by Heel Analysis Systems established on an external server.The data will be transferred securely over HTTPS.
Study NCT00946777 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systane® Ultra
Description: Systane® Ultra 1-2 drops, 4 times per day for 30 days
Study NCT04378920 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LEAF-4L6715
Description: LEAF-4L6715
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foraminal Enlargement / Irrigating solutions / Filling materials
Description: Instrumentation with foraminal enlargement and various irrigation solutions and filling materials will be performed according to the allocated group.~The foraminal enlargement provides better results in the bacterial removal of the apical portion of the root canal. This instrumentation will be done with the Reciproc 40 or 50 system in the apical foramen, determined by the apical locator.~To contribute to disinfection of the root canal, sodium hypochlorite and chlorhexidine are the most widely used irrigators. Sodium hypochlorite has a broad antimicrobial spectrum and an effective ability to dissolve organic matter and necrotic tissue; while chlorhexidine shows substantivity and antimicrobial residual activity when used as an irrigating substance.~Besides that, MTA Fillapex or AH Plus will be used and the recommended filling technique will be lateral condensation.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Foraminal Enlargement / Irrigating solutions / Filling materials
Description: Instrumentation with foraminal enlargement and various irrigation solutions and filling materials will be performed according to the allocated group.~The foraminal enlargement provides better results in the bacterial removal of the apical portion of the root canal. This instrumentation will be done with the Reciproc 40 or 50 system in the apical foramen, determined by the apical locator.~To contribute to disinfection of the root canal, sodium hypochlorite and chlorhexidine are the most widely used irrigators. Sodium hypochlorite has a broad antimicrobial spectrum and an effective ability to dissolve organic matter and necrotic tissue; while chlorhexidine shows substantivity and antimicrobial residual activity when used as an irrigating substance.~Besides that, MTA Fillapex or AH Plus will be used and the recommended filling technique will be lateral condensation.
Study NCT00333658 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal setting and work feedback group
Description: Goal setting and feedback using WBI
Study NCT03599453 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo Biopsy
Study NCT03599453 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chemokine Modulation Therapy
Description: Undergo chemokine modulation therapy
Study NCT03599453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Description: Given by mouth
Study NCT03599453 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Interferon Alfa-2b
Description: Given intravenously
Study NCT03599453 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rintatolimod
Description: Given intravenously
Study NCT03599453 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given intravenously
Study NCT00223795 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Single point cane
Description: Participants with symptomatic knee osteoarthritis will undergo gait evaluation with and without a single point cane.
Study NCT05181254 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: health dialogue
Description: The visual health assessment formulary is based on detailed questions about food, physical activity, heredity, smoking, alcohol, stress and mental illness and measurements such as BMI, blood pressure and blood fats. Patients fill in a web-based questionnaire resulting in a visual colorful scale showing a risk assessment (Figure 1). The Health Dialogue is a prognostic tool that provides an estimate of the increase in risk with current lifestyle habits. The use has shown improvement of lifestyle habits such as smoking cessation, lower intake of fat and higher physical activity level as well as reduced mortality in a long-term follow-up.
Study NCT01638039 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Tests
Description: Stool, blood, urine and saliva samples
Study NCT01230047 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducational course
Description: Psychoeducational course on mindfulness and lifestyle interventions for depression and anxiety
Study NCT03760627 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Refugees Mindfulness Resiliency Training
Description: The intervention consists of meditation, guided imagery, yoga and exercise, biofeedback; self-expression in words, drawings, and movement; and small group support to demonstrate to participants techniques that they can use to self-manage their own stress and trauma.
Study NCT03760627 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Mindfulness Resiliency Training
Description: The intervention consists of meditation, guided imagery, yoga and exercise, biofeedback; self-expression in words, drawings, and movement; and small group support to demonstrate to participants techniques that they can use to self-manage their own stress and trauma.
Study NCT03201562 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aceclidine+tropicamide combination
Description: Ophthalmic Solution
Study NCT03201562 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aceclidine
Description: Ophthalmic Solution
Study NCT03201562 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Vehicle
Description: Ophthalmic Solution
Study NCT01470040 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: discontinuation of aspirin therapy
Description: discontinuation of aspirin therapy
Study NCT01470040 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: continuation of aspirin therapy
Description: continuation of pre-injury low dose aspirin therapy as per previous medical indication
Study NCT03567798 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: UPLAT
Description: Carica papaya leaf Extract + Tinospora cardifolia Extract
Study NCT03567798 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: aPDT will be performed with 0.01% methylene blue solution and it will be inserted into the root canal for 5 minutes. The excess will be removed and irradiation will be performed inside the root canal with the red laser of Índio Gálio Alumínio Fósforo (660nm, Laser Duo, MMOptics, São Paulo, SP, Brazil) for 90 seconds. Laser therapy with Gallium-Aluminum-Arsenic infrared laser (808nm, Laser Duo, MMOptics, São Paulo, SP, Brazil) will be performed on the gingiva from the vestibular face and on the palatal / lingual face, both located in the periapical region for 40 seconds.
Study NCT04926571 — intervention group
Intervention type: DRUG
Intervention: Dexamethasone Oral
Description: New users of Dexamethasone
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive ultrasonic irrigation
Description: PUI will be performed with Newtron P5 ultrasound (Satelec / Acteon Group, Bordeaux, France), at intensity 9 and with a 25mm (# 0.25, taper 0.00). The protocol of use will be 3 sequences of 20 seconds of ultrasonic activation with 2 ml of sodium hypochlorite 2.5% in each root canal.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OHIP-14
Description: Patients will respond a quality of life questionnaire (OHIP-14) on the day of endodontic treatment, on the 7th day and on the 30th day.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: OHIP-14
Description: Patients will respond a quality of life questionnaire (OHIP-14) on the day of endodontic treatment, on the 7th day and on the 30th day.
Study NCT02429960 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Analgesia monitor (PhysioDoloris®)
Description: Comparison of three different analgesia monitoring systems (PhysioDoloris®, SPI® and AlgiScan®).
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assessment of pain and edema
Description: The analysis of the postoperative symptoms will be performed by the visual analog pain scale at 1th, 2th, 3th, 4th, 5th, 6th, 7th, 14th and 30th days and by the clinical evaluation of edema in 48 and 72 hours.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Assessment of pain and edema
Description: The analysis of the postoperative symptoms will be performed by the visual analog pain scale at 1th, 2th, 3th, 4th, 5th, 6th, 7th, 14th and 30th days and by the clinical evaluation of edema in 48 and 72 hours.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assessment of periapical lesion
Description: The periapical lesion repair will be evaluated clinically and radiographically at 3, 6, 12, 18 and 24 months.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Assessment of periapical lesion
Description: The periapical lesion repair will be evaluated clinically and radiographically at 3, 6, 12, 18 and 24 months.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Longevity of rehabilitations
Description: The teeth will be rehabilitated with resin and glass fiber post. The longevity of rehabilitations will be performed clinically and radiographically for 24 months.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Longevity of rehabilitations
Description: The teeth will be rehabilitated with resin and glass fiber post. The longevity of rehabilitations will be performed clinically and radiographically for 24 months.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: The analysis of the postoperative symptoms will be performed by the visual analog pain scale at 1th, 2th, 3th, 4th, 5th, 6th, 7th, 14th and 30th days and by the clinical evaluation of edema in 48 and 72 hours.
Study NCT03704857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ozone therapy
Description: The analysis of the postoperative symptoms will be performed by the visual analog pain scale at 1th, 2th, 3th, 4th, 5th, 6th, 7th, 14th and 30th days and by the clinical evaluation of edema in 48 and 72 hours.
Study NCT03865537 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cold snare EMR
Description: Participants will have their large polyp removed without electrocautery
Study NCT03865537 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Hot snare EMR
Description: Participants will have their large polyp removed with electrocautery
Study NCT03865537 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Eleview injection
Description: Participants will have their polyp submucosally injected with Eleview
Study NCT03865537 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Eleview injection
Description: Participants will have their polyp submucosally injected with Eleview
Study NCT03865537 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Placebo injection
Description: Participants will have their polyp submucosally injected with placebo
Study NCT03865537 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Placebo injection
Description: Participants will have their polyp submucosally injected with placebo
Study NCT02355158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: clonidine hydrochloride topical gel, 0.1%
Study NCT02429960 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Analgesia monitor (SPI®)
Description: Comparison of three different analgesia monitoring systems (PhysioDoloris®, SPI® and AlgiScan®).
Study NCT02429960 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Analgesia monitor (AlgiScan®)
Description: Comparison of three different analgesia monitoring systems (PhysioDoloris®, SPI® and AlgiScan®).
Study NCT02429960 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Remifentanil
Description: Remifentanil will be increased step-by-step from 0.05 mcg/kg/min to 0.2 mcg/kg/min. After ensuring a steady-state period of remifentanil infusion of at least 5 minutes, the standardized painful stimuli will be applied.
Study NCT02427490 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem-Solving Intervention
Description: The problem-solving approach that will be taught in the problem-solving intervention is based on the ADAPT model, which encourages participants to follow five steps when solving problems: focus on adopting a positive attitude to problem-solving, define the problem and set goals, generate a list of alternative solutions to the problem, predict consequences of the alternative solutions, and try implementing the most promising solution from among the list of alternatives. The problem-solving intervention will be delivered by a trained interventionist in three structured sessions using videoconferencing tools.
Study NCT02427490 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unenhanced Monitoring
Description: Study participant completes standardized questionnaires upon study enrollment and at two, four, and eight weeks after study enrollment.
Study NCT02427490 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Unenhanced Monitoring
Description: Study participant completes standardized questionnaires upon study enrollment and at two, four, and eight weeks after study enrollment.
Study NCT04461886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NPC-12G gel
Description: NPC-12G gel is containing 0.2% Sirolimus
Study NCT04452279 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iStent or iStent inject implantation with concomitant cataract surgery
Description: Standard phacoemulsification cataract surgery followed by ab interno implantation of either iStent or iStent inject trabecular micro-bypass stent(s). Preoperatively and at specified visits through 3 months postoperative, patients will complete evaluations of their ocular surface disease (specifically OSDI score, hyperemia, corneal/conjunctival staining, and tear break-up time).
Study NCT02365948 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Certolizumab Pegol
Description: * Active Substance: Certolizumab Pegol~* Pharmaceutical Form: Prefilled syringes~* Concentration: 200 mg/mL~* Route of Administration: Subcutaneous injection
Study NCT02365948 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: * Active Substance: Placebo~* Pharmaceutical Form: Prefilled syringes~* Concentration: 0.9 % Saline~* Route of Administration: Subcutaneous injection
Study NCT03697876 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRO-165
Description: PRO-165 Chondroitin sulfate 0.18% / sodium hyaluronate 0.2%, ophthalmic gel. Prepared by Sophia Laboratories, S.A. of C.V., Zapopan, Jalisco, Mexico.
Study NCT02365948 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: * Active Substance: Placebo~* Pharmaceutical Form: Prefilled syringes~* Concentration: 0.9 % Saline~* Route of Administration: Subcutaneous injection
Study NCT03697876 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Artelac
Description: Artelac® Nightime Gel. 0.2% Carbomer, ophthalmic gel. Made in Germany by: Dr. Gerhard Mann Chem Pharm. Imported and marketed by: Bausch \& Lomb México, S.A. de C.V.
Study NCT00981630 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Live attenuated Japanese encephalitis virus
Description: 0.5 mL,Subcutaneous
Study NCT01795248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liraglutide
Description: 1.8 mg liraglutide
Study NCT00981630 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Live attenuated Japanese encephalitis virus
Description: 0.5 mL, Subcutaneous
Study NCT00981630 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: ChimeriVax™ diluent (Placebo)
Description: 0.5 mL, Subcutaneous
Study NCT01795248 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Liraglutide without the GLP-1 analogue
Study NCT00321594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: belinostat
Description: Given IV
Study NCT00861549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phencynonate hydrochloride
Description: 2mg/tablet